OBJECTIVE: To demonstrate improved healing of a midline laparotomy after application of mesenchymal stromal cells and platelet-rich plasma on a collagen matrix and introduce a potential cellular-based therapy for the prevention of incisional hernia formation. BACKGROUND: Up to 10 % of laparotomies are complicated by postoperative incisional hernias. Despite continuous improvements in surgical technique and technology, hernia rates have remained constant. Cell-based therapies focused on augmentation of the body's natural healing properties could reduce hernia formation. METHODS: Midline laparotomies were performed on 42 Lewis rats. Three groups were studied: (1) primary repair only, (2) primary repair with CollaTape™ (CoTa) overlay and platelet-rich plasma (PRP), and (3) primary repair with CoTa overlay and PRP and bone marrow-derived mesenchymal stromal cells (BM-MSCs). Abdominal wall fascia was recovered at 4 and 8 weeks in each group. Biomechanical testing and histological evaluation was performed. RESULTS: At 4 weeks, there was a twofold increase in tensile strength between groups 1 and 2 and a fourfold increase between groups 1 and 3 (p < 0.001). Group 3 had a 320 % increase in total energy absorption at 4 weeks compared to group 1 and a 142 % increase at 8 weeks (p < 0.001). Vascularization and collagen abundance were significantly increased in group 3 at both time points. CONCLUSION: The addition of BM-MSCs, PRP, and CoTa led to a marked improvement in abdominal wall strength and energy absorption. Histologic evaluation confirmed increased vascularity and collagen abundance consistent with the biomechanical findings. Application of this therapy may ultimately reduce incisional hernia formation.
OBJECTIVE: To demonstrate improved healing of a midline laparotomy after application of mesenchymal stromal cells and platelet-rich plasma on a collagen matrix and introduce a potential cellular-based therapy for the prevention of incisional hernia formation. BACKGROUND: Up to 10 % of laparotomies are complicated by postoperative incisional hernias. Despite continuous improvements in surgical technique and technology, hernia rates have remained constant. Cell-based therapies focused on augmentation of the body's natural healing properties could reduce hernia formation. METHODS: Midline laparotomies were performed on 42 Lewis rats. Three groups were studied: (1) primary repair only, (2) primary repair with CollaTape™ (CoTa) overlay and platelet-rich plasma (PRP), and (3) primary repair with CoTa overlay and PRP and bone marrow-derived mesenchymal stromal cells (BM-MSCs). Abdominal wall fascia was recovered at 4 and 8 weeks in each group. Biomechanical testing and histological evaluation was performed. RESULTS: At 4 weeks, there was a twofold increase in tensile strength between groups 1 and 2 and a fourfold increase between groups 1 and 3 (p < 0.001). Group 3 had a 320 % increase in total energy absorption at 4 weeks compared to group 1 and a 142 % increase at 8 weeks (p < 0.001). Vascularization and collagen abundance were significantly increased in group 3 at both time points. CONCLUSION: The addition of BM-MSCs, PRP, and CoTa led to a marked improvement in abdominal wall strength and energy absorption. Histologic evaluation confirmed increased vascularity and collagen abundance consistent with the biomechanical findings. Application of this therapy may ultimately reduce incisional hernia formation.
Authors: Young Keul Jeon; Yun Ho Jang; Dong Ryeol Yoo; Si Na Kim; Sang Koo Lee; Myeong Jin Nam Journal: Wound Repair Regen Date: 2010-10-18 Impact factor: 3.617
Authors: Matthew G Stanwix; Arthur J Nam; Helen G Hui-Chou; Jonathan P Ferrari; Harold M Aberman; Michael L Hawes; Kaspar M Keledjian; Luke S Jones; Eduardo D Rodriguez Journal: Ann Plast Surg Date: 2011-04 Impact factor: 1.539
Authors: Derek A DuBay; Xue Wang; Belinda Adamson; William M Kuzon; Robert G Dennis; Michael G Franz Journal: Surgery Date: 2006-07 Impact factor: 3.982
Authors: Maja L Konstantinovic; Pieter Lagae; Fang Zheng; Eric K Verbeken; Dirk De Ridder; Jan A Deprest Journal: BJOG Date: 2005-11 Impact factor: 6.531
Authors: Jacobus W A Burger; Roland W Luijendijk; Wim C J Hop; Jens A Halm; Emiel G G Verdaasdonk; Johannes Jeekel Journal: Ann Surg Date: 2004-10 Impact factor: 12.969
Authors: Man Wo Tsang; Wan Keung R Wong; Chi Sang Hung; Kwok-Man Lai; Wegin Tang; Elaine Y N Cheung; Grace Kam; Leo Leung; Chi Wai Chan; Chung Min Chu; Edward K H Lam Journal: Diabetes Care Date: 2003-06 Impact factor: 19.112
Authors: Maria S Altieri; Gabriel Pagnotti; Angelique Corthals; Kenneth Shroyer; Aurora D Pryor; Mark Talamini; Dana A Telem Journal: Surg Endosc Date: 2016-12-06 Impact factor: 4.584
Authors: Maciej Nowacki; Arkadiusz Jundziłł; Łukasz Nazarewski; Andrzej Kotela; Tomasz Kloskowski; Joanna Skopińska-Wisniewska; Magdalena Bodnar; Aleksander Łukasiewicz; Sławomir Nazarewski; Ireneusz Kotela; Marek Kucharzewski; Marta Pokrywczyńska; Andrzej Marszałek; Tomasz Drewa Journal: Biomed Res Int Date: 2015-02-05 Impact factor: 3.411
Authors: Gian Marco Palini; Lucia Morganti; Filippo Paratore; Federico Coccolini; Giacomo Crescentini; Matteo Nardi; Luigi Veneroni Journal: Int J Surg Case Rep Date: 2017-06-13